跳至主要内容
临床试验/NCT05265624
NCT05265624已完成2 期

A Phase 2 Study of the Value of Pre-symptomatic Genetic Risk Assessment for Age-Related Macular Degeneration

Paul S. Bernstein2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年8月3日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80
试验地点
2
主要终点
Change in Skin Carotenoid Status in Response to Genetic Risk Disclosure as Measured by Reflectance Spectroscopy

研究概览

简要总结

The goals of this study are:

To assess the impact of genetic testing for Age-related Macular Degeneration (AMD) on lifestyle behaviors as measured by systemic and ocular carotenoid status.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

Participants will be masked to their AMD risk until their disclosure. Outcomes assessor and investigator will be masked to treatment assignment until completion of study.

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must be between 18 and 64 years of age.
  • They must also be Caucasian as this genetic test is only validated in Caucasians.
  • They can have a positive family history of AMD but this is not necessary.

排除标准

  • Personal history of AMD
  • Non Caucasian
  • Employee of the Moran or other eye care practice (likely to have more knowledge about AMD than a layperson)
  • Personal history of prior genetic testing for AMD risk
  • Anticipated cataract surgery in the upcoming year (can affect Macular Pigment measurement)
  • Major psychiatric disorder

结局指标

主要结局

Change in Skin Carotenoid Status in Response to Genetic Risk Disclosure as Measured by Reflectance Spectroscopy

时间窗: Baseline and Month 12

Reflectance Spectroscopy (RS) is measured by Reflection Units. Possible scores range from 0 (no carotenoids detected) to greater than 500. Change = (Month 12 Score - Baseline Score).

Change in Skin Carotenoid Status in Response to Genetic Risk Disclosure as Measured by Resonance Raman Spectroscopy

时间窗: Baseline and Month 12

Resonance Raman Spectroscopy (RSS) is measured in Resonance Raman Units (RRU). Possible scores range from 0 (no carotenoids detected) to greater than 100,000. Change = (Month 12 Score - Baseline Score).

次要结局

  • Change in Ocular Carotenoid Status in Response to Genetic Risk Disclosure as Measured by Macular Pigment Optical Volume(Baseline and Month 12)
  • Change in Serum Carotenoid Status in Response to Genetic Risk Disclosure(Baseline and Month 12)

研究者

发起方
Paul S. Bernstein
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Paul S. Bernstein

Professor, Ophthalmology/Visual Sciences

University of Utah

研究点 (2)

Loading locations...

相似试验

Unknown
2 期
Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
NCT01729481Ludwig-Maximilians - University of Munich150
终止
不适用
Melanoma Accuracy Study; Phase 2Melanoma
NCT03464604Nova Scotia Health Authority121
终止
2 期
Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDSAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)Adult Acute Myeloblastic Leukemia With Maturation (M2)Adult Acute Myeloblastic Leukemia Without Maturation (M1)Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Adult Acute Myelomonocytic Leukemia (M4)Adult Erythroleukemia (M6a)Adult Pure Erythroid Leukemia (M6b)Previously Treated Myelodysplastic SyndromesRecurrent Adult Acute Myeloid LeukemiaRefractory Anemia With Excess Blasts
NCT01607645Fred Hutchinson Cancer Center7
Unknown
3 期
The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation ProtocolEmbryo's Genetic and Chromosomal Quality
NCT01636505European Hospital200
已完成
不适用
Progression of Disease in Patients Newly Diagnosed With Glaucoma and Glaucoma Suspects Participating in the GATE StudyGlaucoma
NCT03394521University of Aberdeen326